Translational Pharmaceutical Perspectives on Quinones as Antioxidant and Antidiabetic Agents in Diabetes and Its Complications
Pharmaceutics · 20.09.2026 · 18 (9) · 1191
DOI: 10.3390/pharmaceutics18091191 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 20.09.2026. Verfasst von Krishnendu Adhikary und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Laboratory Technology, Paramedical College Durgapur, Durgapur 713212, West Bengal, India. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 352 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Diabetes mellitus (DM) is an extremely complex metabolic disorder, with many factors contributing to persistent hyperglycaemia, redox dysregulation, and micro- and macrovascular damage over time. There is growing evidence that oxidative stress is one of the main mechanisms of β-cell damage, insulin resistance, and consequent tissue damage, pointing to the need for therapies to modulate metabolic and redox responses. The extensive nature of quinones has revealed that they can be potential dual-acting redox-active compounds that may have antioxidant and antidiabetic activities.
Objectives
This review aims to evaluate quinones from a pharmaceutical perspective, considering the chemical diversity and structure–activity relationships, the physicochemical parameters pertinent to drug development, and the mechanisms of action in terms of glucose homeostasis, insulin signalling, mitochondrial protection, and glycoxidative damage.
Methods
Narrative review of the evidence from medicinal chemistry, experimental pharmacology, pharmacokinetics, formulation research, and clinical studies of the potential role of quinones in diabetes and its complications. The paper addresses the relationship between chemical structure and biological activity, redox-dependent mechanisms of action, tissue-protective actions, challenges associated with delivery, toxicity, and recent approaches to formulation.
Results
Quinones influence several processes implicated in diabetes, including mitochondrial dysfunction, oxidative stress, pancreatic β-cell injury, insulin signalling impairment, AGE-RAGE activation, and chronic inflammation. Currently, CoQ10 has the strongest evidence in humans, while thymoquinone (TQ), pyrroloquinoline quinone (PQQ), anthraquinones, and mitochondria-targeted derivatives have mainly cellular and animal studies to support them. Low solubility, variable systemic exposure, rapid metabolism, and the potential for pro-oxidant effects at high concentrations continue to hamper therapeutic development of these compounds.
Conclusions
Future research scopes will rely on rational derivatisation, precision delivery technologies, and clinically validated safety frameworks to translate redox pharmacology into effective therapeutic interventions.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Laboratory Technology, Paramedical College Durgapur, Durgapur 713212, West Bengal, India.
- Research and Development Cell, Lovely Professional University, Pharwara 144411, Punjab, India.
- Department of Pharmacy, Faculty of Allied Health Sciences, University of Jaffna, Jaffna 40000, Sri Lanka.
- Department of Medical Laboratory Technology, Dr. B. C. Roy Academy of Professional Courses, Fuljhore, Durgapur 713206, West Bengal, India.
- Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Hajipur, Vaishali 844102, Bihar, India.
- Department of Biotechnology, Brainware University, Barasat, Kolkata 700125, West Bengal, India.
ORCID-Profile: Krishnendu Adhikary, Thirtsha Shohani Godwin, Adsaya Karunanithi, Riya Sarkar, Md Abubakar, Sayoni Nag, Saurav Barman, Nilanjana Datta, Rajkumar Maiti
Zitieren
APA
Adhikary, K., Godwin, T. S., Karunanithi, A., Sarkar, R., Abubakar, M., Nag, S., Barman, S., Datta, N., & Maiti, R. (2026). Translational Pharmaceutical Perspectives on Quinones as Antioxidant and Antidiabetic Agents in Diabetes and Its Complications. Pharmaceutics, 18(9), 1191. https://doi.org/10.3390/pharmaceutics18091191
Vancouver
Adhikary K, Godwin TS, Karunanithi A, Sarkar R, Abubakar M, Nag S, et al. Translational Pharmaceutical Perspectives on Quinones as Antioxidant and Antidiabetic Agents in Diabetes and Its Complications. Pharmaceutics. 2026;18(9):1191. doi:10.3390/pharmaceutics18091191
BibTeX
@article{Adhikary2026,
author = {Adhikary, Krishnendu and Godwin, Thirtsha Shohani and Karunanithi, Adsaya and Sarkar, Riya and Abubakar, Md and Nag, Sayoni and Barman, Saurav and Datta, Nilanjana and Maiti, Rajkumar},
title = {Translational Pharmaceutical Perspectives on Quinones as Antioxidant and Antidiabetic Agents in Diabetes and Its Complications},
journal = {Pharmaceutics},
year = {2026},
volume = {18},
number = {9},
pages = {1191},
doi = {10.3390/pharmaceutics18091191}
}
EUVIMED